Our study aimed to address this knowledge gap by assessing the prognostic value of YKL-40 in relation to cancers associated with obesity and type 2 diabetes in a contemporary cohort of individuals newly diagnosed with type 2 diabetes. Here, CHI3L1 is linked to obesity due to melanocortin 4 receptor deficiency.